Involvement of Tyr1472 phosphorylation of NMDA receptor NR2B subunit in postherpetic neuralgia in model mice
- Sawako Unezaki†1,
- Atsushi Sasaki†2,
- Tamaki Mabuchi1,
- Shinji Matsumura1,
- Tayo Katano1,
- Takanobu Nakazawa3,
- Naoko Nishio4,
- Tsugunobu Andoh2,
- Tadashi Yamamoto3,
- Terumasa Nakatsuka4,
- Yasushi Kuraishi2 and
- Seiji Ito1Email author
© Unezaki et al.; licensee BioMed Central Ltd. 2012
Received: 18 February 2012
Accepted: 13 June 2012
Published: 21 August 2012
Postherpetic neuralgia is spontaneous pain and allodynia that persist long after the disappearance of the cutaneous lesions caused by herpes zoster. Inoculation of mice with herpes simplex virus-1 causes herpes zoster-like skin lesions and herpetic and postherpetic pain. Although NMDA receptors have been suggested to be involved in postherpetic pain as in other types of neuropathic pain, the neural mechanism remains unclear. NMDA receptor NR2B subunit is the most tyrosine-phosphorylated protein in the brain, and Tyr1472 is the major phosphorylation site of this subunit.
To elucidate the role of Tyr1472 phosphorylation of the NR2B subunit in herpetic and postherpetic allodynia, we inoculated herpes simplex virus-1 into the unilateral hind paw of knock-in mice with a mutation of Tyr1472 of the NR2B subunit to Phe (Y1472F-KI). On day 7 post-inoculation, acute herpetic allodynia was observed in more than 80% of the inoculated wild-type and Y1472F-KI mice. Y1472F-KI mice showed significantly reduced intensity and incidence of postherpetic allodynia on days 45–50 post-inoculation as compared with wild-type mice. The innervation in the skin at the postherpetic neuralgia phase was retained to a greater extent in the Y1472F-KI mice. The level of activating transcription factor-3 mRNA, a marker of axonal damage, increased much less in the dorsal root ganglia (DRGs) of Y1472F-KI mice than in those of wild-type mice; and the level of nerve growth factor mRNA significantly increased in wild-type mice, but not at all in Y1472F-KI mice on day 7 post-inoculation. Production of nerve growth factor was at the basal level in the skin of both groups of mice on day 50 post-inoculation. Nerve growth factor and glial cell-derived neurotrophic factor stimulated neurite outgrowth of cultured DRG neurons from Y1472F-KI mice, similarly or less so as they did the outgrowth of those from wild-type mice. Wild-type DRG neurons were more susceptible to glutamate neurotoxicity than Y1472F-KI ones.
Taken together, the present data suggest that phosphorylation of the NR2B subunit at its Tyr1472 is involved in the development of postherpetic allodynia due to nerve damage and that the nerve damage at the acute herpetic phase is correlated with the incidence of postherpetic pain.
Herpes zoster, which is characterized by clustered vesicles in the skin and severe pain, is caused by the reactivation of varicella zoster virus (VZV, human herpes virus type-3), in the sensory ganglia of humans . Patients with herpes zoster complain of severe spontaneous pain and allodynia, which is pain due to a non-noxious stimulus. In some herpes zoster patients, pain persists long after healing of the skin lesions, so-called postherpetic neuralgia . Once established, postherpetic neuralgia is particularly difficult to treat and is often resistant to conventional analgesics. The neural mechanisms of the induction and maintenance of postherpetic neuralgia are still unclear.
Takasaki et al.[2, 3] previously established a mouse model of herpetic and postherpetic pain by using human herpes virus 1 (herpes simplex virus type-1, HSV-1). When mice were given a transdermal HSV-1 inoculation into a hind paw, they showed herpes zoster-like skin lesions throughout the inoculated dermatome and pain-related behaviors . Pain-related behaviors (herpetic allodynia) and vesicles became apparent 5 days after the inoculation, and the skin lesions healed 10 days later [2, 3]. In one-third of the mice, the pain-related behaviors subsided by day 20 post inoculation; and in the rest of the mice, such behaviors (postherpetic allodynia) lasted long after the skin lesions had completely healed [3, 4]. Based on data they had obtained by using this mouse model, Sasaki et al.  recently suggested that herpetic and postherpetic allodynia are mediated by nitric oxide (NO) in the dorsal horn and that inducible nitric oxide synthase (iNOS) and neuronal NOS (nNOS) are responsible for herpetic and postherpetic allodynia, respectively. Many studies including ours have demonstrated that activation of the NMDA subtype of glutamate receptors and subsequent NO production is a fundamental event in neurotransmission and synaptic plasticity in pain transmission in the spinal cord [5, 6]. Garry et al.  demonstrated that the VZV-induced pain state is attenuated by intrathecal administration of an NMDA receptor antagonist and that the profile of VZV infection-induced phenotype changes in dorsal root ganglia (DRGs) are similar to those in other neuropathic pain models. We showed earlier that an increase in nNOS activity associated with Tyr1472 phosphorylation of the NR2B subunit in the superficial dorsal horn of the spinal cord reflects the neuropathic pain state even 1 week after nerve injury . For elucidation of the role of Tyr1472 phosphorylation of the NR2B subunit in vivo, knock-in mice in which Tyr1472 of the NR2B subunit is mutated to phenylalanine (Y1472F-KI) were previously generated; and the results showed that Tyr1472 phosphorylation is critical for neuropathic pain and fear learning [9–11]. In the present study, we took advantage of this mouse model of herpetic and postherpetic pain produced by HSV-1 inoculation, in which alterations of levels of signaling molecules in the pain transmission pathway can be followed over 7 weeks in relation to pain-like behaviors in vivo. Applying this model to Y1472F-KI mice, we examined the role of NR2B phosphorylation in herpetic and postherpetic allodynia.
Involvement of NR2B phosphorylation in postherpetic allodynia
Restoration of the structure and innervation of the skin
Production of nerve growth factor (NGF) in the skin
Expression of neurotrophins in DRG
Decrease in intensity of NGF- and GDNF-sensitive fibers in the dorsal horn of the spinal cord at postherpetic neuralgia
Neurite outgrowth and neurotoxicity of DRG neurons
Finally we examined glutamate neurotoxicity toward DRG neurons by measuring LDH release. When DRG neurons were cultured with glutamate at 0.5 mM for 24 h, it did not cause the release of LDH from Y1472F-KI DRG neurons; whereas it significantly increased the release from the naive wild-type ones (Figure 8B).
Involvement of Tyr1472 phosphorylation of NR2B subunit in postherpetic pain
By using wild-type and Y1472F-KI mice as nerve injury models, we recently demonstrated that phosphorylation of the NR2B subunit of the NMDA receptor is involved in neuropathic pain [10, 11]. Y1472F-KI mice are born in the expected Mendelian ratios, appear healthy in terms of general behaviors, and show normal gross cytoarchitecture in their brain and spinal cord [9, 10]. The expression level of NR2B and the basic properties of NMDA receptors are absolutely normal in the amygdala  and spinal cord  of Y1472F-KI mice. However, the Ca2+ response to glutamate is reduced after L5 spinal nerve transection injury, and the impaired NMDA receptor-mediated CaMKII signaling does not produce neuropathic pain, in Y1472F-KI mice . In this study, we demonstrated by use of Y1472F-KI mice as an established mouse model of postherpetic pain that phosphorylation of the NR2B subunit affected in a positive manner the incidence of postherpetic allodynia, but not acute herpetic allodynia. In the wild-type mice inoculated with HSV-1, all mice developed mechanical allodynia; and in 81% of them the pain was sustained even after the skin shingles had healed, exhibiting the symptom of postherpetic neuralgia (Figure 1). The behavioral results are consistent with previous studies with the same animal model [3, 4]. On the other hand, all Y1472F-KI mice also developed allodynia on day 7 after HSV-1 inoculation, but the pain-related score was significantly decreased after day 35; and allodynia was detected in only 41% of the mice on day 50 post-inoculation. There was no Y1472F-KI mouse with strong pain. The attenuation of postherpetic pain in Y1472F-KI mice is consistent with the results of a previous study using an NMDA receptor antagonist , which suggested that the NMDA receptor signaling pathway is involved in the development of postherpetic pain. Histochemical studies on adult DRG show 2 broad classes of unmyelinated C fibers: The population positive for CGRP/SP and TrkA, the high-affinity receptor for NGF, represents roughly 40% of DRG neurons in rodents; whereas the IB4-binding, GDNF-sensitive population represents roughly 30% . NMDA-induced currents in the spinal cord were significantly attenuated by GDNF and enhanced by NGF in Y1472F-KI mice, but not in wild-type mice (Figure 7A). The decrease in GDNF-sensitive fibers labeled with IB4 was 68% in Y1472F-KI mice, lower than that in wild-type mice (82%), suggesting that GDNF might contribute to the reduction of intensity of postherpetic pain. Interestingly, the NGF mRNA level increased on days 7 and 50 post-inoculation only in the DRGs of wild-type mice, but not in those of Y1472F-KI mice (Figure 5). Although NGF/TrkA signals are reported to contribute to the development and maintenance of neuropathic pain [15, 16], the role of NGF in the development of postherpetic pain remains unknown.
Higher density of nerve fibers in the skin associated with reduction in postherpetic allodynia in Y1472F-KI mice
NMDA receptors located in the synaptic membranes of the spinal cord play an important role in neuropathic pain and postoperative pain due to neuronal plasticity and central sensitization [17–19]. NMDA receptors are also expressed in peripheral tissues and DRG neurons [20–22], suggesting a potential role of NMDA receptors in pain processing in the periphery [23, 24]. On day 7 post-inoculation, shingles were observed along the lumbar dermatome, and the skin structure and cutaneous innervation were damaged. The skin structures recovered from these injuries on days 15–20 (not shown) [2, 3], but the cutaneous innervation was markedly reduced in the wild-type mice even on day 50 (Figure 3). In Y1472F-KI mice, the degree of cutaneous innervation on the injured side also decreased, as compared with the contralateral side; but the extent of decrease was less than that on the injured side of the wild-type mice. Since cutaneous innervation was markedly decreased in the injured side of Thy1-YFP mice on day 7 after inoculation ( Additional File 1: Figure S1), the disappearance of PAG9.5 immunoreactivity in the skin on day 7 (Figure 3) was due to the loss of nerve fibers rather than the alteration in immunoreactivity. It has been reported that cutaneous innervation is decreased in patients with postherpetic neuralgia and that intraepidermal nerve fiber density is negatively correlated with the severity of pain in patients with herpes zoster [25–27] as well as in those with other sensory neuropathies and in several animal models [28–30]. In fact, it was reported that excision of painful skin relieved long-lasting postherpetic pain in a patient .
Reduced damage to peripheral nerve results in reduced postherpetic allodynia
DRG neurons contain NR1, NR2B, NR2C, and NR2D, but not NR2A, subunits . Furthermore, NR2B subunits are predominantly expressed on small-diameter primary afferents . There are 2 possibilities for higher density of nerve fibers in the skin of Y1472F-KI mice (Figure 3): reduced damage to nerve fibers and better regeneration of lost nerve fibers in the skin. The findings in the present study demonstrate that Tyr1472 phosphorylation of NR2B subunit was involved in the damage to nerve fibers for the following reasons: (1) When herpes virus (HSV-1 or VZV-infected cells) is inoculated transdermally, the viral DNA and the gene products are detected in the DRGs and alter the gene expression of neuropeptides and ion channels in these ganglia [2, 7]. ATF3 is highly induced in all injured DRG neurons after peripheral nerve injury, and the increase in the number of ATF3-positive DRG neurons is correlated positively with pain behavior . The ATF3 expression level was higher on day 7 post-inoculation in wild-type mice than in Y1472F-KI mice, and the increased expression was still retained on day 50 (Figure 5), indicating that axonal damage was more severe in the skin of wild-type mice than in that of Y1472F-KI mice. Similarly, GDNF-sensitive neurons labeled with IB4 in the spinal dorsal horn were higher in number in Y1472F-KI mice than in wild-type mice (Figure 6). (2) It has been reported that the NGF level in the DRG increases in other neuropathic pain model animals [33, 34] and that NGF/TrkA signals contribute to the development and maintenance of neuropathic pain [35, 36]. Although the NGF level was previously reported to increase in the injured skin [12, 37], it had returned to the basal level on day 50 after the HSV-1 injection (Figure 4). Therefore it is unlikely that NGF directly activated and/or sensitized the nociceptors on free nerve endings at the postherpetic pain phase. (3) The neurite outgrowth from adult DRGs prepared from Y1472F-KI mice was similarly facilitated by NGF, but the responsiveness of these mice to GDNF was reduced as compared with that of wild-type mice to it (Figure 8A). On the other hand, LDH release, indicative of cell damage, was observed in wild-type DRG neurons treated with glutamate at 0.5 mM, whereas no release was observed in the case of the Y1472F-KI DRG (Figure 8B). Taken together, these results demonstrate that reduced nerve damage by HSV-1 in eruptions lowered the incidence of postherpetic neuralgia. This notion is consistent with earlier findings that the inhibition of acute herpetic allodynia results in a decreased incidence of delayed postherpetic allodynia .
The application of the postherpetic pain model by HSV-1 inoculation into Y1472F-KI mice is useful for examining the factors contributing to the transition from acute herpetic pain to delayed postherpetic pain. Phosphorylation of the NR2B subunit was involved in the pathogenesis of neuropathic pain not only in the spinal cord but also in that of postherpetic pain in the periphery.
Animal experiments were approved by the Animal Experimentation Committee of Kansai Medical University and the Animal Care Committee at University of Toyama, and were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. C57BL/6 mice were obtained from Japan SLC (Shizuoka, Japan). Y1472F-KI mice were generated by a knock-in technique, substituting Tyr1472 (Y) of NR2B subunit with Phe (F). The absence of Tyr1472 phosphorylation was confirmed, and the mice were backcrossed to the C57BL/6 J background as described previously . Eight- to 10-week old mice were used for HSV-1 inoculation.
Mice were inoculated with HSV-1 as described previously . Briefly, HSV-1 (7401 H strain; 1 × 106 plaque-forming units in 10 μ l) was inoculated onto the shin skin on the lumbar dermatome of the right hind paw after scarification with 27-gauge needles. The contralateral hind paw was not inoculated.
Assessment of allodynia
Punctate allodynia of the hind paw was assessed as described previously . Briefly, mice were acclimated to the instrument, and then their plantar skin was pressed by a von Frey filament having a bending force of 1.6 mN (ca. 0.16 g). The responses to the stimulus were ranked as follows: 0, no response; 1, lifting the hind paw; 2, flinching or licking the hind paw. The stimulation was applied 6 times, and the average served as the pain-related score. Mice that showed 0.5 or higher as their pain-related score were considered to have allodynia; and those with ≥ 1.0, to have strong allodynia.
On day 7 or 50 after the inoculation, the mice were anesthetized with 50 mg/kg of pentobarbital and perfused transcardially with a fixative solution (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4). The hindlimb skin on the lumbar dermatome was harvested from both inoculated and contralateral sides. The lumbar spinal cord was also harvested from the mice on day 50 post-inoculation. Tissues were post-fixed by immersion in the above-mentioned fixative solution at 4°C overnight, and then incubated in 30% sucrose in phosphate-buffered saline (PBS) overnight. Tissues were frozen in Tissue Mount® (Chiba Medical, Saitama, Japan) or O.C.T. compound (Sakura Finetek, Tokyo, Japan) and cut transversely into 10- or 20-μm sections on a cryostat. The skin sections were stained with hematoxylin and eosin, and images were captured with a color cooled charge-coupled device camera mounted on a microscope (E1000; Nikon, Tokyo, Japan).
Tissue sections were first incubated for 30 min in a blocking solution (5% normal goat serum and 0.25% Triton-X 100 in PBS) and then incubated with rat monoclonal anti-SP antibody (1:100; AbD Serotec, Oxford, UK) or rabbit polyclonal antibodies against PGP9.5 (1:500; Abcam, Cambridge, UK) or CGRP (1:4000, Sigma, St. Louis, MO), overnight at 4°C. After having been washed with PBS, the sections were incubated with Alexa 488-conjugated goat anti-rat or Alexa 546-conjugated goat anti-rabbit IgG antibody (1:500; Invitrogen, Carlsbad, CA) for 1 h, and washed. The sections were then counterstained and mounted with coverslips by using Vectashield mounting medium containing 4',6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA). The fluorescent images were obtained with a Zeiss laser scanning confocal microscope (LSM 510 META; Carl Zeiss, Jena, Germany). A stack of images of tissue sections was created from a series of 34–48 consecutive images taken along the z-axis, each having a 0.38-μm thickness, with Zeiss C-Apochromat 40 x/1.2 W.
Sections of spinal cords were preincubated for 20 min at room temperature with 0.1% Triton-X 100 in PBS supplemented with 0.1 mM CaCl2, MgCl2, and MnCl2 and then incubated overnight at 4°C with 50 μ g/ml of fluorescein isothiocyanate-conjugated Bandeiraea simplicifolia isolectin B4 (IB4, Sigma) in the preincubation buffer.
Quantitative image analysis
All image analyses were conducted with ImageJ software (http://rsbweb.nih.gov/ij/). Quantification of epidermal nerve fibers immunoreactive for PGP9.5 and CGRP was done by using skin sections on day 50 post-inoculation. As for PGP9.5-positive epidermal nerve fibers, 8 to 10 photos of the affected skin and 5 or 6 photos of the contralateral skin were taken at regular intervals per section per mouse.
The lengths of PGP9.5-positive intraepidermal nerve fibers were measured with ImageJ software, and the total length (per mm of epidermis) of all nerve fibers in each image was calculated. The number of CGRP-positive nerve fibers in the epidermis was counted in 3 sections per mouse at a magnification of 630. The mean numbers of nerve fibers per mm epidermis were calculated. For measurement of CGRP-, SP-, and IB4-fluorescence intensity in the spinal cord, every 6 sections of the dorsal horn were analyzed per mouse. The fluorescent images were converted to binary images, and the area of labeled neurons was measured.
Enzyme-linked immunosorbent assay (ELISA)
On day 50 post-inoculation, the hair of mice was clipped; and the hindlimb skin of both inoculated and contralateral sides was harvested. A skin-wound model was made as previously described . Briefly, adult C57BL/6 and Y1472F-KI mice were anesthetized by pentobarbital, after which the hair on their back was clipped and full-thickness skin wounds 5 mm in diameter were prepared by cutting out the skin. After 24 h, the skin approx. 2–3 mm around the wound was obtained and stored at −80°C. The frozen skin was ground into a powder in a mortar chilled by liquid nitrogen, and the skin powder was weighed. The powder was then suspended in lysis buffer (20 mM Tris, 137 mM NaCl, 1% NP40, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 μ g/ml trasirol; pH 8), and the mixture was subsequently stirred for 30 min on ice to extract NGF. After centrifugation at 15,000 rpm for 20 min, the supernatant was recovered; and the NGF content was then measured by use of an ELISA kit (Promega, Madison, WI) according to the manufacturer’s protocol.
Total RNAs were extracted from L4 and L5 DRGs of wild-type and Y1472F-KI mice on days 7 and 50 post-inoculation by using Trizol reagent as recommended by the manufacturer (Invitrogen). cDNAs were synthesized from the RNA by use of reverse transcriptase with p(dN)6 random primer. Real-time PCR was carried out by using an MJ Research Opticon 2 system (BioRad, Hercules, CA) with SYBR green and the following primers (5'-to-3' direction): aagactggagcaaaatgatg and gacttggtgactgacatctc for ATF3, cagacactctggatctagac and gattggaggctcggcacttg for NGF, cgttgagaaagctgcttcag and tcggctttgctcagtggatc for BDNF, ctgtctgcctggtgttgct and cgtcatcaaactggtcagga for GDNF, gagactgaatgaccgaactc and tatccgcctggatcagcttg for NT3, and ttgggcgcctggtcaccagggctgc and atttgccgtgagtggagtcatac for GAPDH. Each sample was analyzed in triplicate, and the data were normalized to GAPDH by using the comparative Ct method.
The methods used for obtaining spinal cord slice preparations were described previously . In brief, adult wild-type and Y1472F-KI mice (8–10 weeks of age) were deeply anesthetized by an intraperitoneal injection of urethane (1.2 g/kg), and then lumbosacral laminectomy was performed. The lumbosacral spinal cord (L1–S3) was removed and placed in preoxygenated Krebs’ solution at 1–3°C. Immediately after the removal of the spinal cord, the mice were given an overdose of urethane and then killed by exsanguination. The pia-arachnoid membranes were removed after cutting all the ventral and dorsal roots near the root entry zone. The spinal cord was mounted on a microslicer, and then a 650-mm-thick transverse slice was cut. The slice was placed on a nylon mesh in the recording chamber, which had a volume of 0.5 ml, and was then perfused at a rate of 10–15 ml/min with Krebs’ solution saturated with 95% O2 and 5% CO2 and maintained at 36 ± 1°C. The Krebs’ solution contained 117 mM NaCl, 3.6 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 25 mM NaHCO3, and 11 mM glucose (pH = 7.4).
Blind whole-cell patch-clamp recordings were made from substantia gelatinosa (SG) neurons with patch-pipette electrodes having a resistance of 5–10 MΩ . The patch-pipette solution was composed of 135 mM potassium gluconate, 5 mM KCl, 0.5 mM CaCl2, 2 mM MgCl2, 5 mM EGTA, 5 mM HEPES, and 5 mM ATP-Mg (pH = 7.2). Signals were acquired with a patch-clamp amplifier (Axopatch 200B; Molecular Devices, Sunnyvale, CA). Data were digitized with an A/D converter (Digidata 1440A, Molecular Devices), stored, and analyzed with a personal computer using the pCLAMP data acquisition program (Version 10.2, Molecular Devices). SG neurons were viable for up to 24 h in slices perfused with preoxygenated Krebs’ solution. However, all the recordings described here were obtained within 12 h. Whole-cell patch-clamp recordings were stable for up to 4 h. Drugs were dissolved in Krebs’ solution and applied by perfusion via a 3-way stopcock without any change in the perfusion rate or the temperature. The time necessary for the solution to flow from the stopcock to the surface of the spinal cord slice was approximately 10 sec.
L4, L5, and L6 DRGs were dissected from C57BL/6 and Y1472F-KI mice at 4 to 5 weeks of age. Some mice were subjected to a unilateral axotomy. The left sciatic nerve was ligated and cut at mid-thigh level under pentobarbital anesthesia. Seven days later, the animals were killed; and their ganglia were then collected. The ganglia were digested with 0.7 mg/ml collagenase type II (Sigma) in Dulbecco's modified Eagle medium (DMEM) for 50 min at 37°C followed by 0.05% trypsin-EDTA for 5 min at 37°C, and then the digestion was stopped by the addition of 0.2 mg/ml of trypsin inhibitor (Sigma). The cells were dispersed by pipetting and then filtered through a 70-μ m cell strainer (BD). The cell number was counted, and the cells were plated onto poly-D-lysine and laminin-coated glass cover slips (in 24-well plates) at a density of 2.5 × 103 cells/ml and cultured in Neurobasal medium with 2% B27 supplement. To some wells 10–100 ng/ml of NGF or GDNF (PeproTech, Rocky Hill, NJ) was added, and the cells were then cultured at 37°C in a humidified atmosphere containing 5% CO2. After 22–26 h of culture, the neurons were fixed in 4% paraformaldehyde for 15 min on ice and washed with PBS. Non-specific binding sites were blocked with blocking solution (2% bovine serum albumin, 0.25% Triton X-100 in PBS) for 30 min at room temperature, and then the fixed cells were incubated overnight at 4°C with anti-PGP9.5 antibody (Ultraclone) diluted 1:1000 in blocking solution. After having been washed with PBS, the neurons were incubated with a 1:500 dilution of Alexa 546-conjugated goat anti-rabbit IgG (Invitrogen) for 1 h at room temperature and washed in PBS. After the coverslips had been mounted to glass slides with Vectashield (Vector Laboratories), the immunostained neurons were observed with a Zeiss laser scanning confocal microscope (LSM 510 META, Carl Zeiss); and 200–400 cells per sample were counted to measure the percentage of cells with neurite outgrowth. The cells that extended neurites to a length greater than 2 cell-body diameters were classified as process-bearing neurons.
Release of lactate dehydrogenase (LDH)
LDH release was measured with an LDH-Cytotoxic Test kit (Wako Pure Chemicals, Osaka, Japan) according to manufacturer's instructions. Briefly, after DRG neurons (3,000/well) had been incubated without or with 0.1–1 mM glutamate in a 96-well plate for 24 h, 50 μl of culture medium was transferred from each well to a well of another 96-well plate; and 50 μl of freshly prepared coloring solution was added to it. LDH activity was colorimetrically measured at 560 nm by use of a plate reader (Enspire 2300 Multilabel Reader, PerkinElmer, Waltham, MA).
Data were presented as mean ± standard deviation (SD). The Mann–Whitney U-test was used for the statistical analysis of allodynia data, and Bonferroni t-test or Student's t-test (two-tailed) was used for other analyses, by using SigmaPlot ver. 12 (Systat Software, Inc., San Jose, CA). P values of less than 0.05 were considered significant.
This work was supported in part by grants from the programs Grants-in-Aid for Scientific Research (B) and (C) from Japan Society for the Promotion of Science, the Science Research Promotion Fund of the Japan Private School Promotion Foundation, and Japan Foundation of Applied Enzymology.
- Loeser JD: Herpes zoster and postherpetic neuralgia. Pain 1986, 25: 149–164. 10.1016/0304-3959(86)90089-8View ArticlePubMedGoogle Scholar
- Takasaki I, Andoh T, Shiraki K, Kuraishi Y: Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 2000, 86: 95–101. 10.1016/S0304-3959(00)00240-2View ArticlePubMedGoogle Scholar
- Takasaki I, Sasaki A, Andoh T, Nojima H, Shiraki K, Kuraishi Y: Effects of analgesics on delayed postherpetic pain in mice. Anesthesiology 2002, 96: 1168–1174. 10.1097/00000542-200205000-00021View ArticlePubMedGoogle Scholar
- Sasaki A, Mabuchi T, Serizawa K, Takasaki I, Andoh T, Shiraki K, Ito S, Kuraishi Y: Different roles of nitric oxide synthase-1 and −2 between herpetic and postherpetic allodynia in mice. Neuroscience 2007, 150: 459–466. 10.1016/j.neuroscience.2007.09.067View ArticlePubMedGoogle Scholar
- Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52: 127–136. 10.1016/0304-3959(93)90124-8View ArticlePubMedGoogle Scholar
- Garthwaite J: Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008, 27: 2783–2802. 10.1111/j.1460-9568.2008.06285.xPubMed CentralView ArticlePubMedGoogle Scholar
- Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM: Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005, 118: 97–111. 10.1016/j.pain.2005.08.003View ArticlePubMedGoogle Scholar
- Abe T, Matsumura S, Katano T, Mabuchi T, Takagi K, Xu L, Yamamoto A, Hattori K, Yagi T, Watanabe M, Nakazawa T, Yamamoto T, Mishina M, Nakai Y, Ito S: Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 2005, 22: 1445–1454. 10.1111/j.1460-9568.2005.04340.xView ArticlePubMedGoogle Scholar
- Nakazawa T, Komai S, Watabe AM, Kiyama Y, Fukaya M, Arima-Yoshida F, Horai R, Sudo K, Ebine K, Delawary M, Goto J, Umemori H, Tezuka T, Iwakura Y, Watanabe M, Yamamoto T, Manabe T: NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO J 2006, 25: 2867–2877. 10.1038/sj.emboj.7601156PubMed CentralView ArticlePubMedGoogle Scholar
- Matsumura S, Kunori S, Mabuchi T, Katano T, Nakazawa T, Abe T, Watanabe M, Yamamoto T, Okuda-Ashitaka E, Ito S: Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472. Eur J Neurosci 2010, 32: 798–810. 10.1111/j.1460-9568.2010.07348.xView ArticlePubMedGoogle Scholar
- Katano T, Nakazawa T, Nakatsuka T, Watanabe M, Yamamoto T, Ito S: Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain. Neuropharmacology 2011, 60: 609–616. 10.1016/j.neuropharm.2010.12.005View ArticlePubMedGoogle Scholar
- Kawamoto K, Matsuda H: Nerve growth factor and wound healing. Prog Brain Res 2004, 146: 369–384.View ArticlePubMedGoogle Scholar
- Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, Noguchi K: Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci 2000, 15: 170–182. 10.1006/mcne.1999.0814View ArticlePubMedGoogle Scholar
- Snider WD, McMahon SB: Tackling pain at the source: new ideas about nociceptors. Neuron 1998, 20: 629–632. 10.1016/S0896-6273(00)81003-XView ArticlePubMedGoogle Scholar
- Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F: The function- neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci USA 2007, 104: 2985–2990. 10.1073/pnas.0611253104PubMed CentralView ArticlePubMedGoogle Scholar
- Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A, Matsumoto M, Konno K, Ushio H, Matsuda K: Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998, 187: 297–306. 10.1084/jem.187.3.297PubMed CentralView ArticlePubMedGoogle Scholar
- Petrenko AB, Yamakura T, Baba H, Shimoji K: The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg 2003, 97: 1108–1116.View ArticlePubMedGoogle Scholar
- Bleakman D, Alt A, Nisenbaum ES: Glutamate receptors and pain. Semin Cell Dev Biol 2006, 17: 592–604. 10.1016/j.semcdb.2006.10.008View ArticlePubMedGoogle Scholar
- Gu X, Wu X, Liu Y, Cui S, Ma Z: Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine. Mol Pain 2009, 5: 76. 10.1186/1744-8069-5-76PubMed CentralView ArticlePubMedGoogle Scholar
- Marvizón JC, McRoberts JA, Ennes HS, Song B, Wang X, Jinton L, Corneliussen B, Mayer EA: Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J Comp Neurol 2002, 446: 325–341. 10.1002/cne.10202View ArticlePubMedGoogle Scholar
- Ma QP, Hargreaves RJ: Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 2000, 101: 699–707. 10.1016/S0306-4522(00)00419-XView ArticlePubMedGoogle Scholar
- Genever PG, Maxfield SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, Skerry TM: Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 1999, 112: 337–342. 10.1046/j.1523-1747.1999.00509.xView ArticlePubMedGoogle Scholar
- Du J, Zhou S, Coggeshall RE, Carlton SM: N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 2003, 118: 547–562. 10.1016/S0306-4522(03)00009-5View ArticlePubMedGoogle Scholar
- Jang JH, Kim D-W, Sang Nam T, Se Paik K, Leem JW: Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat. Neuroscience 2004, 128: 169–176. 10.1016/j.neuroscience.2004.06.040View ArticlePubMedGoogle Scholar
- Oaklander AL: The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 2001, 92: 139–145. 10.1016/S0304-3959(00)00481-4View ArticlePubMedGoogle Scholar
- Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, Fields HL: Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 1996, 3: 205–214. 10.1006/nbdi.1996.0021View ArticlePubMedGoogle Scholar
- Petersen KL, Fields HL, Brennum J, Sandroni P, Rowbotham MC: Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000, 88: 125–133. 10.1016/S0304-3959(00)00311-0View ArticlePubMedGoogle Scholar
- Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC: Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999, 53: 1634–1640. 10.1212/WNL.53.8.1634View ArticlePubMedGoogle Scholar
- Quattrini C, Jeziorska M, Boulton AJ, Malik RA: Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 2008, 31: 140–145. 10.2337/dc08-s235View ArticlePubMedGoogle Scholar
- Christianson JA, Riekhof JT, Wright DE: Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 2003, 179: 188–199. 10.1016/S0014-4886(02)00017-1View ArticlePubMedGoogle Scholar
- Petersen KL, Rice FL, Suess F, Berro M, Rowbotham MC: Relief of post-herpetic neuralgia by surgical removal of painful skin. Pain 2002, 98: 119–126. 10.1016/S0304-3959(02)00029-5View ArticlePubMedGoogle Scholar
- Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN: Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006, 26: 1281–1292. 10.1523/JNEUROSCI.3388-05.2006View ArticlePubMedGoogle Scholar
- Shen H, Chung JM, Chung K: Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury. Mol Brain Res 1999, 64: 186–192. 10.1016/S0169-328X(98)00314-3View ArticlePubMedGoogle Scholar
- Fukuoka T, Kondo E, Dai Y, Hashimoto N, Noguchi K: Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci 2001, 21: 4891–4900.PubMedGoogle Scholar
- Zhuang ZY, Xu H, Clapham DE, Ji RR: Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 2004, 24: 8300–8309. 10.1523/JNEUROSCI.2893-04.2004View ArticlePubMedGoogle Scholar
- Basbaum AI, Bautista DM, Scherrer G, Julius D: Cellular and molecular mechanisms of pain. Cell 2009, 139: 267–284. 10.1016/j.cell.2009.09.028PubMed CentralView ArticlePubMedGoogle Scholar
- Wild KD, Bian D, Zhu D, Davis J, Bannon AW, Zhang TJ, Louis J-C: Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J Pharmacol Exp Ther 2007, 322: 282–287. 10.1124/jpet.106.116236View ArticlePubMedGoogle Scholar
- Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H: Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 2004, 74: 2619–2626. 10.1016/j.lfs.2004.01.005View ArticlePubMedGoogle Scholar
- Nakatsuka T, Ataka T, Kumamoto E, Tamaki T, Yoshimura M: Alteration in synaptic inputs through C-afferent fibers to substantia gelatinosa neurons of the rat spinal dorsal horn during postnatal development. Neuroscience 2000, 99: 549–556. 10.1016/S0306-4522(00)00224-4View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.